Search for Clinical Trial Results
Basal Cell Nevus Syndrome - 27 Studies Found
Status | Study |
Completed |
Study Name: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face Condition: Neoplastic Syndrome Date: 2007-06-20 Interventions: Drug: tazarotene Tazarotene is a member of the acetylenic class of retinoids. |
Completed |
Study Name: Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants Condition:
Date: 2007-02-08 Interventions:
|
Completed |
Study Name: Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome Condition: Non-melanomatous Skin Cancer Date: 2001-09-13 Interventions: Drug: celecoxib |
Completed |
Study Name: Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients Condition:
|
Recruiting |
Study Name: Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) Condition: Basal Cell Carcinoma in Basal Cell Nevus Syndrome Date: 2015-01-21 Interventions: Drug: SUBA-Itraconazole Subjects will receive an oral dose of 300 mg SUBA-Itraconazole daily. |
Withdrawn |
Study Name: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condition: Basal Cell Carcinoma Date: 2010-07-06 Interventions:
|
Recruiting |
Study Name: Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas Condition: Basal Cell Carcinoma Date: 2015-12-14 Interventions: Drug: Vismodegib Vismodegib 150 mgs po qd for 3 months |
Active, not recruiting |
Study Name: A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas Condition: Basal Cell Carcinoma Date: 2013-03-19 Interventions:
|
Recruiting |
Study Name: A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma Condition:
|
Completed |
Study Name: The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases Condition:
|